Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease

• Milda Vysniauskaite ,

  Contributed equally to this work with: Milda Vysniauskaite, Hans-Jörg Hertfelder, Gerhard J. Molderings

  Affiliation Institute of Exp. Haematology & Transfusion Medicine, University Hospital of Bonn, Bonn, Germany

  ⨯
• Hans-Jörg Hertfelder ,

  Contributed equally to this work with: Milda Vysniauskaite, Hans-Jörg Hertfelder, Gerhard J. Molderings

  Affiliation Institute of Exp. Haematology & Transfusion Medicine, University Hospital of Bonn, Bonn, Germany

  ⨯
• Johannes Oldenburg,

  Affiliation Institute of Exp. Haematology & Transfusion Medicine, University Hospital of Bonn, Bonn, Germany

  ⨯
• Peter Dreßen,

  Affiliation Department of Internal Medicine, St. Franziskus Hospital, Eitorf, Germany

  ⨯
• Stefan Brettner,

  Affiliation Department of Oncology, Hematology and Palliative Care, County Hospital, Waldbröl, Germany

  ⨯
• Jürgen Homann,

  Affiliation Community Hospital St. Elisabeth, Bonn, Germany

  ⨯
• Gerhard J. Molderings

  Contributed equally to this work with: Milda Vysniauskaite, Hans-Jörg Hertfelder, Gerhard J. Molderings

  * E-mail: molderings@uni-bonn.de

  Affiliation Institute of Human Genetics, University Hospital of Bonn, Bonn, Germany

  ⨯